Cardlytics Ownership
| CDLX Stock | USD 4.09 0.02 0.49% |
Shares in Circulation | First Issued 2016-12-31 | Previous Quarter 49.1 M | Current Value 50 M | Avarage Shares Outstanding 28.6 M | Quarterly Volatility 9.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cardlytics |
Cardlytics Stock Ownership Analysis
About 62.0% of the company shares are held by institutions such as insurance companies. The book value of Cardlytics was currently reported as 1.38. The company recorded a loss per share of 6.4. Cardlytics had not issued any dividends in recent years. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. It employs 710 people. For more info on Cardlytics please contact Karim Temsamani at 888 792 5802 or go to https://www.cardlytics.com.Besides selling stocks to institutional investors, Cardlytics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cardlytics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cardlytics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cardlytics Quarterly Liabilities And Stockholders Equity |
|
Cardlytics Insider Trades History
About 5.0% of Cardlytics are currently held by insiders. Unlike Cardlytics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cardlytics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cardlytics' insider trades
Cardlytics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cardlytics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cardlytics backward and forwards among themselves. Cardlytics' institutional investor refers to the entity that pools money to purchase Cardlytics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | D. E. Shaw & Co Lp | 2024-09-30 | 573.3 K | Baillie Gifford & Co Limited. | 2024-09-30 | 567.4 K | General Equity Holdings Lp | 2024-09-30 | 533.5 K | Rbf Llc | 2024-09-30 | 488.1 K | Ubs O'connor Llc | 2024-09-30 | 450 K | Renaissance Technologies Corp | 2024-09-30 | 410.9 K | Pb Investment Partners, L.p. | 2024-09-30 | 397.1 K | Charles Schwab Investment Management Inc | 2024-09-30 | 390.3 K | Gsa Capital Partners Llp | 2024-09-30 | 382.3 K | Blackrock Inc | 2024-06-30 | 3.2 M | Vanguard Group Inc | 2024-09-30 | 2.7 M |
Cardlytics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardlytics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardlytics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardlytics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cardlytics Outstanding Bonds
Cardlytics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardlytics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardlytics bonds can be classified according to their maturity, which is the date when Cardlytics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| US14162VAB27 Corp BondUS14162VAB27 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Cardlytics Corporate Filings
F4 | 15th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 21st of August 2024 An amendment to a previously filed Form 8-K | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.